23 January 2012
GlaxoSmithKline (GSK) has selected Jones Lang LaSalle (JLL) as its global real estate provider.
The contract covers around 80 million square feet
across 750 locations and includes consulting and the management of
vacant and sub-let properties, according to a statement from JLL.
JLL has been providing global real estate services to GlaxoSmithKline alongside other service providers for more than 10 years.
“From 2007, Jones Lang LaSalle and Cushman & Wakefield jointly advised GSK,” said Sue Pictor, director of global real estate for GlaxoSmithKline.
However, a move to a single property provider should bring financial benefits to the pharmaceuticals firm.
“A twin service provider model has provided a quality transactional service up to this point," said Pictor. "However, we believe that the single provider model will allow significant financial benefits through 2012 and beyond. It will also allow us to have a more strategic partnership so that we can evolve our global real estate strategy and to provide high-quality transaction services."
“Our focus remains to provide the best service and work in partnership with our client’s Global Real Estate team, to deliver new workplace solutions across the globe, including emerging markets in both Asia and Latin America," said Tom Bayne-Jardine, lead director corporate solutions at Jones Lang LaSalle.
This GlaxoSmithKline deal follows other recent global contracts for JLL’s corporate solutions division, including Volvo Cars Corporation, UBS, HSBC and Doosan Power Systems.
Other news for Monday, 23 January 2012
GSK picks JLL in property deal
HVCA name-change is a “reflection of reality”
BaxterStorey wins sweet deal with Haribo
Mitie makes security appointment
Contracts round-up
FM World blog: Learning from disaster
website
website